WHO ICTRP trial
Study of curcumin on improving non-alcoholic simple fatty liver disease
ChiCTR2200058052 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200058052 |
|---|---|
| Public title | Study of curcumin on improving non-alcoholic simple fatty liver disease |
| Scientific title | Mechanism of curcumin regulating NPC1L1 expression and plasma membrane translocation against non-alcoholic simple fatty liver |
| Primary sponsor | School of Public Health, Sun Yat-sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Non-alcoholic fatty liver disease (NAFLD) |
| Interventions | Group A:Curcumin;Group B:Placebo |
| Registration date | Mar 27, 2022 |
| Target size | Group A:40;Group B:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: